---
document_datetime: 2023-09-21 17:03:08
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/stayveer-epar-all-authorised-presentations_en.pdf
document_name: stayveer-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0164713
conversion_datetime: 2025-12-27 23:19:29.962761
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging       | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|---------------------------|-------------|
| EU/1/13/832/001  | Stayveer          | 62.5 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC/alu) | 56 tablets  |
| EU/1/13/832/002  | Stayveer          | 125 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC/alu) | 56 tablets  |
| EU/1/13/832/003  | Stayveer          | 62.5 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC/alu) | 112 tablets |
| EU/1/13/832/004  | Stayveer          | 125 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC/alu) | 112 tablets |
| EU/1/13/832/005  | Stayveer          | 62.5 mg    | Film-coated tablet    | Oral use                  | Bottle (HDPE)             | 56 tablets  |
| EU/1/13/832/006  | Stayveer          | 125 mg     | Film-coated tablet    | Oral use                  | Bottle (HDPE)             | 56 tablets  |